COVID-19: Invasion, pathogenesis and possible cure–A review

P Nitin, R Nandhakumar, B Vidhya, S Rajesh… - Journal of Virological …, 2022 - Elsevier
Abstract Today, Coronavirus disease (COVID-19) which is believed to be transmitted from
bats to humans where the people of Wuhan city, China exposed to the wet animal market is …

Kabasura Kudineer (KSK), a poly-herbal Siddha medicine, reduced SARS-CoV-2 viral load in asymptomatic COVID-19 individuals as compared to vitamin C and zinc …

S Natarajan, C Anbarasi, P Sathiyarajeswaran… - Trials, 2021 - Springer
Introduction Despite several ongoing efforts in biomedicine and traditional medicine, there
are no drugs or vaccines for coronavirus disease 2019 (COVID-19) as of May 2020; …

[HTML][HTML] Ayurvedic formulations: Potential COVID-19 therapeutics?

AAM Ali, A Bugarcic, N Naumovski, R Ghildyal - Phytomedicine Plus, 2022 - Elsevier
Abstract Background: While Molnupiravir and Paxlovid have recently been approved for use
in some countries, there are no widely available treatments for COVID-19, the disease …

Efficacy of two siddha polyherbal decoctions, Nilavembu Kudineer and Kaba Sura Kudineer, along with standard allopathy treatment in the management of mild to …

A Srivastava, M Rengaraju, S Srivastava, V Narayanan… - Trials, 2021 - Springer
Background and aim Globally, the ongoing pursuit in exploring an effective drug to combat
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus has not met with …

Anti-inflammatory effect of Kaba Sura Kudineer (AYUSH approved COVID-19 drug)-A Siddha poly-herbal formulation against lipopolysaccharide induced …

SP Jose, M Ratheesh, S Sheethal, S Rajan… - Journal of …, 2022 - Elsevier
Ethnopharmacological relevance Medicinal importance and potential activity of Siddha
herbal formulations have proved over several centuries against a wide range of causative …

In silico screening of potential phytocompounds from several herbs against sars-cov-2 indian delta variant b. 1.617. 2 to inhibit the spike glycoprotein trimer

M Bharathi, BS Sivamaruthi, P Kesika, S Thangaleela… - Applied Sciences, 2022 - mdpi.com
In October 2020, the SARS-CoV-2 B. 1.617 lineage was discovered in India. It has since
become a prominent variant in several Indian regions and 156 countries, including the …

[HTML][HTML] Clinical outcomes among COVID-19 patients managed with modern and traditional Siddha medicine–A retrospective cohort study

R Meenakumari, K Thangaraj, A Sundaram… - Journal of Ayurveda and …, 2022 - Elsevier
Abstract Background Kabasura Kudineer (KSK) is a Siddha polyherbal decoction
recommended by the Ministry of AYUSH and the Tamil Nadu government to prevent and …

Visiting Indian Hospitals Before, During and After Covid

E Pavithra, B Janakiramaiah, LVN Prasad… - … Journal of Uncertainty …, 2022 - World Scientific
The prevailing COVID-19 situation has brought in temporary and permanent changes in the
attitude and lifestyle of people. Starting from Hand sanitizers and face masks, it extends to …

[HTML][HTML] A Prospective, Controlled, Pilot Study of Personalised Add-on Ayurveda Treatment in High-Risk Type II Diabetes COVID-19 Patients

S Kumar, SS Eranezhath, VK Vishwanathan… - Journal of Herbal …, 2024 - Elsevier
Introduction In hospitalised mild to moderate COVID-19 patients with pre-existing type 2
diabetes, we evaluated the efficacy of add-on customised Ayurveda intervention as …

Understanding the activating mechanism of the immune system against COVID-19 by Traditional Indian Medicine: Network pharmacology approach

DT Kumar, MSS Devi, SU Kumar, A Sherlin… - Advances in protein …, 2022 - Elsevier
Abstract Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) transmissions
are occurring rapidly; it is raising the alarm around the globe. Though vaccines are currently …